Newsroom press releases

16/12/19 - 14:10

Diasorin receives FDA clearance for Simplexa VZV Swab Direct Molecular assay (571.47 KB)

Products Molecular

Download

06/12/19 - 18:12

Press Release (262.61 KB)

Other

Download

06/12/19 - 18:11

Press Release (262.7 KB)

Other

Download

06/12/19 - 18:08

Communication on total amount of voting rights (281.87 KB)

Other

Download

27/11/19 - 7:59

DIASORIN LAUNCHES THE LIAISON QUANTIFERON-TB GOLD PLUS ASSAY IN PARTNERSHIP WITH QIAGEN IN THE US MARKET (531.97 KB)

Products Immunodiagnostic

Download

11/11/19 - 9:46

DIASORIN LAUNCHES PRIMER PAIR FOR CANDIDA AURIS IN THE US MARKET (159.93 KB)

Products Molecular

Download

06/11/19 - 13:00

Record free cash flow generation along with growth in revenues and profitability for DiaSorin in the first 9 months of 2019 (621.09 KB)

Financial Data

Download

30/10/19 - 9:55

DIASORIN LAUNCHES LIAISON® XL ZIKA CAPTURE IgM II TEST FOR THE DETECTION OF ZIKA VIRUS IN THE US MARKET (579.27 KB)

Products Immunodiagnostic

Download

22/10/19 - 14:10

DIASORIN LAUNCHES LIAISON HCV TEST FOR HEPATITIS C DIAGNOSIS IN THE US MARKET (358.37 KB)

Products Immunodiagnostic

Download

07/10/19 - 10:20

Communication on total amount of voting rights (282.21 KB)

Other

Download

24/09/19 - 10:10

DiaSorin launches VZV Direct molecular test in Europe (369.67 KB)

Products Molecular

Download

31/07/19 - 13:00

DiaSorin Board of Directors approves first half 2019 results. Growth in revenues and profitability. (687.57 KB)

Financial Data

Download

10/06/19 - 18:23

DiaSorin presents its 2019-2022 Industrial Plan (548.2 KB)

Financial Data

Download

05/06/19 - 7:38

DiaSorin and QIAGEN collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease (448.98 KB)

Acquisition / Partnership Immunodiagnostic

Download

29/05/19 - 15:06

DiaSorin launches VZV DIRECT molecular test in the United States (360.87 KB)

Products Molecular

Download

09/05/19 - 13:14

DiaSorin Group reports growth in profitability and strong free cash flow generation in the first quarter 2019 (728.82 KB)

Financial Data

Download

06/05/19 - 15:19

DiaSorin launches ELASTASE-1 test for the diagnosis of chronic exocrine pancreatitis on LIAISON XL (416.77 KB)

Products Immunodiagnostic

Download

30/04/19 - 12:28

Update Annual Calendar of Corporate Events 2019 (249.43 KB)

Other

Download

24/04/19 - 17:24

DiaSorin: Shareholders' Meeting 2019 (449.66 KB)

Other

Download

12/04/19 - 8:59

Communication on total amount of voting rights (320.44 KB)

Other

Download

05/04/19 - 9:33

Communication on total amount of voting rights (342.47 KB)

Other

Download

03/04/19 - 20:18

Lists publication (79.68 KB)

Other

Download

03/04/19 - 10:32

DiaSorin launches the anaemia panel on Liaison XL in Europe (416.47 KB)

Products Immunodiagnostic

Download

14/03/19 - 14:16

Growth in revenues, profitability and net profit in 2018 (1.03 MB)

Financial Data

Download

07/03/19 - 11:45

Communication on total amount of voting rights (350.08 KB)

Other

Download

06/03/19 - 8:45

A new Group website for DiaSorin: www.diasoringroup.com (154.5 KB)

Other

Download

07/02/19 - 15:15

Communication on total amount of voting rights (February 7, 2019) (349.86 KB)

Other

Download

31/01/19 - 22:30

DiaSorin launches FDA-cleared LIAISON Calprotectin test in the US market (528.02 KB)

Products Immunodiagnostic

Download

03/01/19 - 13:30

DiaSorin launches Simplexa Bordetella Direct Molecular test in the United States (428.56 KB)

Products Molecular

Download

22/12/10 - 1:00

2011 Financial calendar (180.28 KB)

Financial Data

Download

20/12/10 - 1:00

Dividend may be distributed in June (445.78 KB)

Financial Data

Download

02/12/10 - 1:00

Comment on position Paper on Vitamin D (53.46 KB)

Products Immunodiagnostic

Download

24/11/10 - 1:00

Change in share capital (46.85 KB)

Financial Data

Download

18/11/10 - 1:00

Financial instruments to employees (48.33 KB)

Financial Data

Download

05/11/10 - 1:00

The BoD approves Q3'10 results (414.16 KB)

Financial Data

Download

02/11/10 - 1:00

Change in share capital (313.61 KB)

Financial Data

Download

08/10/10 - 2:00

2010 Financial calendar update (174.1 KB)

Financial Data

Download

30/09/10 - 2:00

Change in share capital (5.25 KB)

Financial Data

Download

24/09/10 - 2:00

Financial instruments to employees (48.81 KB)

Financial Data

Download

16/09/10 - 2:00

Stock options exercised by key managers (195.67 KB)

Financial Data

Download

02/09/10 - 2:00

Financial instruments to employees (24.27 KB)

Financial Data

Download

06/08/10 - 2:00

The BoD approves H1'10 results (287.11 KB)

Financial Data

Download

07/07/10 - 2:00

Agreement with Meridian Inc. (182.7 KB)

Acquisition / Partnership

Download

06/07/10 - 2:00

2010 Financial calendar update (174.1 KB)

Financial Data

Download

02/07/10 - 2:00

Financial instruments to employees (24.37 KB)

Financial Data

Download

01/06/10 - 2:00

Acquisition of MUREX product line (102.6 KB)

Acquisition / Partnership

Download

14/05/10 - 2:00

The BoD approves Q1'10 results (254.05 KB)

Financial Data

Download

27/04/10 - 2:00

Approval of statutory financial statements (182.99 KB)

Financial Data

Download

20/04/10 - 2:00

2010 Financial calendar update (168.23 KB)

Financial Data

Download

14/04/10 - 2:00

Postponement of the term for lists of members of the Board of Auditors (40.34 KB)

Financial Data

Download

09/04/10 - 2:00

China approves new prenatal screening product line on LIAISON (141.08 KB)

Products Immunodiagnostic

Download

02/04/10 - 2:00

Financial instruments to employees (27.79 KB)

Financial Data

Download

22/03/10 - 1:00

The BoD approves FY 2009 results (306.02 KB)

Financial Data

Download

10/03/10 - 1:00

Acquisition of MUREX product line (45.5 KB)

Acquisition / Partnership

Download

01/03/10 - 1:00

2010 Financial calendar update (192.49 KB)

Financial Data

Download

12/02/10 - 1:00

The BoD approves Q4'09 results (213.8 KB)

Financial Data

Download

18/01/10 - 1:00

2010 Financial calendar (103 KB)

Financial Data

Download

Newsroom press releases

Select year

Newsroom press category

Diasorin receives FDA clearance for Simplexa VZV Swab Direct Molecular assay (571.47 KB)

Press Release (262.61 KB)

Press Release (262.7 KB)

Communication on total amount of voting rights (281.87 KB)

DIASORIN LAUNCHES THE LIAISON QUANTIFERON-TB GOLD PLUS ASSAY IN PARTNERSHIP WITH QIAGEN IN THE US MARKET (531.97 KB)

DIASORIN LAUNCHES PRIMER PAIR FOR CANDIDA AURIS IN THE US MARKET (159.93 KB)

Record free cash flow generation along with growth in revenues and profitability for DiaSorin in the first 9 months of 2019 (621.09 KB)

DIASORIN LAUNCHES LIAISON® XL ZIKA CAPTURE IgM II TEST FOR THE DETECTION OF ZIKA VIRUS IN THE US MARKET (579.27 KB)

DIASORIN LAUNCHES LIAISON HCV TEST FOR HEPATITIS C DIAGNOSIS IN THE US MARKET (358.37 KB)

Communication on total amount of voting rights (282.21 KB)

DiaSorin launches VZV Direct molecular test in Europe (369.67 KB)

DiaSorin Board of Directors approves first half 2019 results. Growth in revenues and profitability. (687.57 KB)

DiaSorin presents its 2019-2022 Industrial Plan (548.2 KB)

DiaSorin and QIAGEN collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease (448.98 KB)

DiaSorin launches VZV DIRECT molecular test in the United States (360.87 KB)

DiaSorin Group reports growth in profitability and strong free cash flow generation in the first quarter 2019 (728.82 KB)

DiaSorin launches ELASTASE-1 test for the diagnosis of chronic exocrine pancreatitis on LIAISON XL (416.77 KB)

Update Annual Calendar of Corporate Events 2019 (249.43 KB)

DiaSorin: Shareholders' Meeting 2019 (449.66 KB)

Communication on total amount of voting rights (320.44 KB)

Communication on total amount of voting rights (342.47 KB)

Lists publication (79.68 KB)

DiaSorin launches the anaemia panel on Liaison XL in Europe (416.47 KB)

Growth in revenues, profitability and net profit in 2018 (1.03 MB)

Communication on total amount of voting rights (350.08 KB)

A new Group website for DiaSorin: www.diasoringroup.com (154.5 KB)

Communication on total amount of voting rights (February 7, 2019) (349.86 KB)

DiaSorin launches FDA-cleared LIAISON Calprotectin test in the US market (528.02 KB)

DiaSorin launches Simplexa Bordetella Direct Molecular test in the United States (428.56 KB)

2011 Financial calendar (180.28 KB)

Dividend may be distributed in June (445.78 KB)

Comment on position Paper on Vitamin D (53.46 KB)

Change in share capital (46.85 KB)

Financial instruments to employees (48.33 KB)

The BoD approves Q3'10 results (414.16 KB)

Change in share capital (313.61 KB)

2010 Financial calendar update (174.1 KB)

Change in share capital (5.25 KB)

Financial instruments to employees (48.81 KB)

Stock options exercised by key managers (195.67 KB)

Financial instruments to employees (24.27 KB)

The BoD approves H1'10 results (287.11 KB)

Agreement with Meridian Inc. (182.7 KB)

2010 Financial calendar update (174.1 KB)

Financial instruments to employees (24.37 KB)

Acquisition of MUREX product line (102.6 KB)

The BoD approves Q1'10 results (254.05 KB)

Approval of statutory financial statements (182.99 KB)

2010 Financial calendar update (168.23 KB)

Postponement of the term for lists of members of the Board of Auditors (40.34 KB)

China approves new prenatal screening product line on LIAISON (141.08 KB)

Financial instruments to employees (27.79 KB)

The BoD approves FY 2009 results (306.02 KB)

Acquisition of MUREX product line (45.5 KB)

2010 Financial calendar update (192.49 KB)

The BoD approves Q4'09 results (213.8 KB)

2010 Financial calendar (103 KB)

Price Sensitive